Ciclesonide for the treatment of seasonal allergic rhinitis

References

• Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J. Allergy Clin. Immunol.108, S2–S8 (2001).
   PubMed Web of Science ®Google Scholar
• Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc.28, 3–9 (2007).
   PubMed Web of Science ®Google Scholar
• Blaiss MS. Allergic rhinitis: direct and indirect costs. Allergy Asthma Proc.31(5), 375–380 (2010).
   PubMed Web of Science ®Google Scholar
• Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy62(Suppl. 85), 17–25 (2007).
   PubMed Web of Science ®Google Scholar
• Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy62(Suppl. 85), 9–16 (2007).
   PubMed Web of Science ®Google Scholar
• Stoeck M, Riedel R, Hochhaus G et al.In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J. Pharmacol. Exp. Ther.309(1), 249–258 (2004).
   PubMed Web of Science ®Google Scholar
• Rohatagi S, Luo L, Shen L et al. Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide. Am. J. Ther.12(3), 201–209 (2005).
   PubMedGoogle Scholar
• Sato H, Nave R, Nonaka T et al. Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa. BMC Pharmacol.7, 7 (2007).
   Google Scholar
• Belvisi MG, Bundschuh DS, Stoeck M, et al. Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma. J. Pharmacol. Exp. Ther.314(2), 568–574 (2005).
   PubMed Web of Science ®Google Scholar
• Winkler J, Hochhaus G, Derendorf H. How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proc. Am. Thorac. Soc.1(4), 356–363 (2004).
   PubMedGoogle Scholar
• Nave R, Bethke TD, van Marle SP, Zech K. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects. Clin. Pharmacokinet.43(7), 479–486 (2004).
   PubMed Web of Science ®Google Scholar
• Mutch E, Nave R, McCracken N, Zech K, Williams FM. The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue. Biochem. Pharmacol.73, 1657–1664 (2007).
   PubMed Web of Science ®Google Scholar
• Nave R, Drollmann A, Steinijans VW, Bethke TD. Lack of pharmacokinetic drug–drug interaction between ciclesonide and erythromycin. Int. J. Clin. Pharmacol. Ther.43(6), 264–270 (2005).
   PubMed Web of Science ®Google Scholar
• Bohmer GM, Drollmann A, Gleiter CH, Nave R. Effect of coadministered ketoconazole, a strong cytochrome P450 3A4 enzyme inhibitor, on the pharmacokinetics of ciclesonide and its active metabolite desisobutyryl-ciclesonide. Clin. Pharmacokinet.47(5), 343–349 (2008).
   Google Scholar
• Kim K, Quesada J, Szmaydy-Rikken N et al. Intranasal ciclesonide coadministration with inhaled fluticasone propionate–salmeterol does not suppress cortisol in allergic rhinitis patients. J. Asthma44, 515–520 (2007).
   PubMed Web of Science ®Google Scholar
• Ratner P, Darken P, Wingertzahn M, Shah T. Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis. J. Asthma44, 629–633 (2007).
   PubMed Web of Science ®Google Scholar
• Agertoft L, Pedersen S. Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide. J. Allergy Clin. Immunol.115, 940–945 (2005).
   PubMed Web of Science ®Google Scholar
• Szefler S, Rohatagi S, Williams J et al. Ciclesonide, a novel inhaled steroid, does not affect HPA-axis function in patients with moderate-to-severe persistent asthma. Chest128, 1104–1114 (2005).
   PubMed Web of Science ®Google Scholar
• Lipworth BJ, Kaliner MA, LaForce CF et al. Effect of ciclesonide and fluticasone on hypothalamic–pituitary–adrenal axis function in adults with mild-to-moderate persistent asthma. Ann. Allergy Asthma Immunol.94, 465–472 (2005).
   PubMed Web of Science ®Google Scholar
• Nave R, Herzog R, Laurent A, Wingertzahn MA. Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers. Clin. Ther.31, 2988–2999 (2009).
   Google Scholar
• Ratner P, Wingertzahn MA, Herzog R et al. An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitis. Pulm. Pharmacol. Ther. (2011) (In Press).
   Google Scholar
• Ratner PH, Wingertzahn MA, van Bavel JH et al. Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis. Ann. Allergy Asthma Immunol.97, 657–663 (2006).
   Google Scholar
• Ratner PH, Wingertzahn MA, van Bavel JH, Hampel F, Darken PF, Shah T. Efficacy and safety of ciclesnide nasal spray for the treatment of seasonal allergic rhinitis. J. Allergy Clin. Immunol.118, 1142–1148 (2006).
   PubMed Web of Science ®Google Scholar
• Patel P, Patel D, Kunjibettu S, Hall N, Wingertzahn MA. Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis. Ear Nose Throat J.87(6), 340–353 (2008).
   PubMedGoogle Scholar
• Couroux P, Kunjibettu S, Hall N, Wingertzahn MA. Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis. Ann. Allergy Asthma Immunol.102, 62–68 (2009).
   Google Scholar
• LaForce C, van Bavel J, Meltzer EO, Wingertzahn MA. Efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol once daily for the treament of seasonal allergic rhinitis. Ann. Allergy Asthma Immunol.103, 166–173 (2009).
   Google Scholar
• Ratner PH, Jacobs RL, Mohar D, Huang H, Desai SY, Hinkle J. Evaluation of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol, 80 or 160 micrograms once daily, for the treatment of seasonal allergic rhinitis. Ann. Allergy Asthma Immunol.105, 471–479 (2010).
   PubMed Web of Science ®Google Scholar
• Howland W, Ratner P, Martin B et al. A study evaluating the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol in the relief of nasal symptoms of seasonal allergic rhinitis. J. Allergy Clin. Immunol.127(2), AB200 (2011).
   Google Scholar
• Martin B, Ratner P, Howland W et al. An evaluation of the effect of ciclesonide hydrofluoroalkane nasal aerosol on the ocular symptoms of seasonal allergic rhinitis. J. Allergy Clin. Immunol.127(2), AB201 (2011).
   Google Scholar
• Andrews C, Ratner P, Martin B et al. Results of the Rhinoconjunctivitis Related Quality of Life Questionnaire administered to subjects with seasonal allergic rhinitis following treatment with ciclesonide hydrofluoroalkane nasal aerosol. J. Allergy Clin. Immunol.127(2), AB257 (2011).
   Google Scholar
• Bielory L, Blaiss M, Fineman SM et al. Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology. Ann. Allergy Asthma Immunol.96, 514–525 (2006).
   PubMed Web of Science ®Google Scholar
• Nave R, Wingerzahn MA, Brookman S, Kaida S, Matsunaga T. Safety, tolerability, and exposure of ciclesonide nasal spray in healthy and asymptomatic subjects with seasonal allergic rhinitis. J. Clin. Pharmacol.46(4), 461–467 (2006).
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Derendorf H. The systemic safety of inhaled corticosteroid therapy: a focus on ciclesonide. Ann. Allergy Asthma Immunol.97, 149–157 (2006).
   Google Scholar
• Meltzer EO. Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Ann. Allergy Asthma Immunol.98, 12–21 (2007).
   PubMed Web of Science ®Google Scholar
• Strachan DP. Hay fever, hygiene, and household size. BMJ299, 1259–1260 (1989).
   PubMed Web of Science ®Google Scholar
• Strachan DP. Family size, infection and atopy: the first decade of the ‘hygiene hypothesis’. Thorax55(Suppl. 1), S2–S10 (2000).
   PubMed Web of Science ®Google Scholar
• D’Amato G, Cecchi L. Effects of climate change on environmental factors in respiratory allergic disease. Clin. Exp. Allergy38(8), 1264–1274 (2008).
   PubMed Web of Science ®Google Scholar
• Shea KM, Truckner RT, Peden DB. Climate change and allergic disease. J. Allergy Clin. Immunol.122(3), 443–453 (2008).
   PubMed Web of Science ®Google Scholar
• Ziska L, Knowlton K, Rogers C et al. Recent warming by latitude associated with increased length of ragweed pollen season in central North America. Proc. Natl Acad. Sci. USA108, 4248–4251 (2011).
   PubMed Web of Science ®Google Scholar